# Akari Therapeutics, Plc (AKTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AKTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -19.26M | $ -5.60M | $ 693.0K | $ 18.60M |
| 2025 | $ 0 | $ -17.71M | $ -10.80M | $ 754.0K | $ 28.33M |
| 2024 | $ 0 | $ -20.80M | $ -13.19M | $ 3.26M | $ 22.23M |
| 2023 | $ 0 | $ -10.82M | $ -17.77M | $ 0 | $ -229.0K |
| 2022 | $ 0 | $ -19.83M | $ -15.22M | $ 0 | $ 1.79M |
| 2021 | $ 0 | $ -20.71M | $ -22.40M | $ 0 | $ 5.55M |
| 2020 | $ 0 | $ -21.76M | $ -21.59M | $ 0 | $ 9.38M |
| 2019 | $ 0 | $ -22.22M | $ -16.67M | $ 0 | $ 3.84M |
| 2018 | $ 0 | $ -21.75M | $ -29.82M | $ 0 | $ 13.38M |
| 2017 | $ 0 | $ -43.88M | $ -42.62M | $ 0 | $ 19.98M |
| 2016 | $ 0 | $ -24.96M | $ -33.95M | $ 0 | $ 34.10M |
| 2015 | $ 0 | $ -64.94M | $ -6.97M | $ 0 | $ 48.72M |
| 2014 | $ 144.1K | $ -18.38M | $ -13.45M | $ 533 | $ 4.85M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 1.08 |
| Current Ratio | 0.60 |

## Other views

- [Metrics](https://sponda.capital/en/AKTX.md)
- [Charts](https://sponda.capital/en/AKTX/charts.md)
- [Compare](https://sponda.capital/en/AKTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.